Health Canada drug identification number

DIN 02461528 — BASAGLAR 100 UNIT

BASAGLAR is a solution of Insulin Glargine marketed by ELI LILLY CANADA INC. The full Insulin Glargine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02461528
Brand name
BASAGLAR
Active ingredient
Insulin Glargine
Strength
100 UNIT
Dosage form
SOLUTION
Route
SUBCUTANEOUS
Manufacturer
ELI LILLY CANADA INC
Health Canada status
MARKETED
Drug class
Long-acting insulin analogue (antidiabetic agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Insulin Glargine products

DINBrandStrengthFormManufacturerStatus
02444844 BASAGLAR 100 UNIT SOLUTION ELI LILLY CANADA INC MARKETED
02245689 LANTUS 100 UNIT SOLUTION SANOFI-AVENTIS CANADA INC MARKETED
02251930 LANTUS 100 UNIT SOLUTION SANOFI-AVENTIS CANADA INC MARKETED
02294338 LANTUS 100 UNIT SOLUTION SANOFI-AVENTIS CANADA INC MARKETED
02526441 SEMGLEE 100 UNIT SOLUTION BIOCON SDN.BHD MARKETED
02493373 TOUJEO DOUBLESTAR 300 UNIT SOLUTION SANOFI-AVENTIS CANADA INC MARKETED
02441829 TOUJEO SOLOSTAR 300 UNIT SOLUTION SANOFI-AVENTIS CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.